Please login to the form below

Not currently logged in
Email:
Password:

PMCPA launches phase 2 of Code consultation

The Prescription Medicines Code of Practice Authority has published the second part of its consultation on proposed amendments to the ABPI Code of Practice

The Prescription Medicines Code of Practice Authority (PMCPA) has published the second part of its consultation on proposed amendments to the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the pharmaceutical industry.

This second phase (Appendix 3) was published on August 4, 2010 and includes proposals for increased transparency regarding pharmaceutical companies employing health professionals and others to act as consultants. The consultation period will close on September 14, 2010, with responses requested by the PMCPA by September 1, 2010.

The first phase was published on June 28, 2010 and included proposed amendments for the provision of promotional aids (Appendices 1 and 2).  Responses to phase one must be received by the PMCPA by August 13, 2010.

The Code of Practice applies to the promotion of medicines to members of the UK health professions and appropriate administrative staff.  It also applies to a number of areas which are non-promotional, including information made available to the public about prescription only medicines. The Code was last updated in 2008.

Full consultation documents are available on the PMCPA website. All responses should be sent to consultations@pmcpa.org.uk

5th August 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

Transforming healthcare through effective collaboration. Making work to feel proud of. www.dovetailstrategies.com...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics